Wednesday, June 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “administration” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 43
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 43 pipeline programs matching "administration" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

43 results for “administration” Back to intelligence hub

Search results

Page 2 of 2
  1. Drugs administration

    Hospital Authority, Hong Kong

    Rotator Cuff Tears of the Shoulder

    phase 1 small molecule active

    1 trial
  2. JWK007 Single intravenous infusion administration

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Duchenne Muscular Dystrophy

    phase 1 mab active

    1 trial
  3. Nicotine Pouches

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Pouch Self-Administration

    phase 1 small molecule active

    1 trial
  4. Olutasidenib Investigational Agent Administration

    RIGEL PHARMACEUTICALS INC

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial
  5. Pharmacy-based methadone administration and dispensing

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 1 small molecule completed

    1 trial
  6. Recombinant adeno-associated virus administration

    Kunming Hope of Health Hospital

    Menkes Syndrome

    phase 1 small molecule terminated

    1 trial
  7. UIC201602 and co-administration of UIC201601 and UIC201602

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial
  8. administration of UI018

    United Therapeutics Europe Ltd

    Hyperlipemia, Mixed

    phase 1 small molecule active

    1 trial
  9. administration of UI058

    United Therapeutics Europe Ltd

    GERD

    phase 1 small molecule completed

    1 trial
  10. administration of UI068

    United Therapeutics Europe Ltd

    Diabetes Mellitus, Type 2

    phase 1 small molecule completed

    1 trial
  11. eASC

    Takeda

    Localized Adverse Reaction to Administration of Drug

    phase 1 gene therapy completed

    1 trial
  12. Amodiaquine plus Artesunate co-administration

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial
  13. Concomitant administration of EV71 vaccine with EPI vaccines

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial
  14. Concomitant administration of EV71vaccine with EPI vaccines

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial
  15. Rosuvastatin and Ezetimibe morning or evening administration

    COLLEGIUM PHARMACEUTICAL, INC

    Hypercholesterolemia

    approved small molecule completed

    1 trial
  16. Forced administration of furosemide

    The First People's Hospital of Lianyungang

    Cytoreductive Surgery

    small molecule completed

    1 trial
  17. Intra-arterial administration of neuroprotective agents

    Hui-Sheng Chen

    Ischemic Stroke

    small molecule active

    1 trial
  18. Intravenous administration of ferric carboxymaltose

    United Therapeutics Europe Ltd

    Lung Hypoxia

    small molecule completed

    1 trial
  19. Uteratonic administration

    Tarsus Pharmaceuticals

    Placenta Abruptio

    small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.